がんにおける好中球・骨髄系細胞 MOC

がん微小環境における好中球 (TAN)、MDSC、TAM、myeloid lineage の役割を統合する。免疫抑制、転移促進、NET 形成、biomarker としての NLR まで横断。

ドメイン定義

含む: TAN polarization (N1/N2 二分法から連続的可塑性スペクトラムへ)、終末分化・老化好中球状態 (CCL3-hi aged neutrophil、SELL-hi → CCL3-lo → CCL3-hi 軌跡)、MDSC (PMN-MDSC, polymorphonuclear myeloid-derived suppressor cell)、NET (neutrophil extracellular trap)、抗原提示性好中球 (HLA-DR+ TAN) と好中球の再プログラム化、好中球による前転移ニッチ形成、NLR (neutrophil-lymphocyte ratio) の予後マーカー性、myeloid を標的とした治療開発 (阻害 + 抗腫瘍方向への再教育)、IO (immuno-oncology) 効果との関連。

含まない: T 細胞・NK 細胞主体の研究 (novel-cancer-modalities / 関連)、骨転移における破骨細胞の役割 (cancer-biology の bone metastasis 部分)。Basic-Immunotherapy のうち myeloid 関連のみ本 MOC で扱い、リンパ球系は除外。

現状の合意 (State of the Field)

腫瘍関連好中球 (TAN) 研究は、2009 年 Fridlender らの N1 (抗腫瘍) /N2 (前腫瘍) 二分法から、単細胞 atlas 時代の連続的可塑性スペクトラムへとパラダイムを移した。NSCLC (non-small cell lung cancer) の scRNA-seq (single-cell RNA sequencing) atlas (Salcher et al. CancerCell 2022)、hN1–hN5 サブセットの定義 (Zilionis et al. Immunity 2019)、膵がんで未熟 (T1) ・成熟 (T2) 好中球がともに腫瘍内で同一の腫瘍促進性 T3 状態 (dcTRAIL-R1 陽性・血管新生性) へ不可逆的に収束する “deterministic reprogramming” の発見 (Ng et al. Science 2024) が、TAN を骨髄での emergency granulopoiesis から組織内での運命収束まで co-option される連続体として再定義した。記述の氾濫を整理するため、発達段階・機能モジュール・定義識別子・組織局在の 4 層分類フレームワークと命名標準化も提唱されている (Ng et al. Immunity 2025)。

NET (neutrophil extracellular trap) は腫瘍生物学の中心機構として確立した。循環腫瘍細胞 (CTC) の捕捉 (Cools-Lartigue et al. JClinInvest 2013)、転移支援 (Park et al. SciTranslMed 2016)、炎症時 NET による休眠癌細胞覚醒 (Albrengues et al. Science 2018)、CCDC25-DNA 受容体軸による転移臓器指向性 (Yang et al. Nature 2020) と機構が積み上げられた。近年は治療そのものが NET を起動して再発を駆動する像が鮮明になった。化学療法は肺線維芽細胞の老化と SASP (senescence-associated secretory phenotype; C3 / CXCL1 / MIF) を介して好中球の NETosis を活性化し、NET 由来の好中球エラスターゼ・MMP9 がラミニン111 を切断して integrin α3β1 を活性化して播種性休眠細胞 (DTC, disseminated tumor cell) を覚醒させる。系譜追跡ツール DormTracer による直接証明では PAD4 阻害薬 GSK484 や DNase I がこの覚醒を完全に遮断し、セノリティクス (ダサチニブ+ケルセチン / ABT-263) と化学療法の併用が腫瘍制御効果を損なわずに転移再発を抑止した (He et al. CancerCell 2025)。DNase I (dornase alfa・AAV 全身投与型)・PAD4 阻害 (GSK484 / BMS-P5 / JBI-589)・neutrophil elastase 阻害 (sivelestat)・CXCR1/2 拮抗 (reparixin / AZD5069 / SX-682)・脱シアル化酵素 E-602 などの NET 標的療法と H3Clip 等の NET バイオマーカーは、化学療法・放射線・ICI (immune checkpoint inhibitor) 抵抗性および癌関連血栓症の克服という文脈で体系化されつつあり、概日リズム依存の夜間 NET ピークから日中 ICI 投与が夕方投与の約 2 倍の全生存を示す観察も統合された (Shahzad et al. NatRevCancer 2026)。

PMN-MDSC と classical neutrophil の境界は依然議論的だが、FATP2 (Veglia et al. Nature 2019)、LOX-1 (Condamine et al. SciImmunol 2016)、フェノタイプ定義 (Veglia et al. JExpMed 2021) によりマーカー層が整理され、MDSC は myeloid diversity の文脈で再概念化された (Lasser et al. NatRevClinOncol 2024)。免疫抑制の分子ハブとして CD300ld が浮上した。PMN-MDSC 上の CD300ld が STAT3-S100A8/A9 経路で腫瘍浸潤と T 細胞抑制を制御すること (Wang et al. Nature 2023) に続き、AlphaFold3 駆動の脂質リガンドスクリーニングで同定されたその結合相手は活性化 CD8+ T 細胞表面のホスファチジルセリンであり、病的活性化好中球が PS[high] T 細胞と直接接触して接触依存的 ROS (reactive oxygen species) 伝達で選択的に抑制すること、中和ナノボディ (L14) と抗 PD-1 併用が MC38 で 60% (9/15)・Renca で 27% (4/15) の完全退縮を達成し、ヒトでは CD300LD 低発現が ICB (immune checkpoint blockade) 奏効と相関することが示された (Wang et al. NatCancer 2026)。pan-cancer では低転写好中球を回収する細胞型確率分類器 (従来比最大 67 倍) が SELL-hi → CCL3-lo → CCL3-hi の種横断的 3 段階分化軌跡を確立し、低酸素ニッチに集積する CCL3 高発現老化好中球が CCL3-CCR1-Bcl2a オートクラインで生存を延長して腫瘍増殖を駆動すること、TCGA 8,305 例で好中球量が腫瘍増殖率や CXCL9:SPP1 マクロファージ極性とは独立した予後不良因子であることが示された (Bolli et al. CancerCell 2026)。一方で抗原提示能を持つ HLA-DR+ TAN サブセットも単細胞・空間アトラスで再現性高く同定され (Marteau et al. CancerCell 2026)、SOX2 高発現腫瘍幹細胞が FADS1/アラキドン酸/PGE2 経路で近傍 TAN の IFN 応答を空間選択的に抑制し免疫療法後の再発ニッチを形成すること (Guo et al. CancerCell 2026) から、好中球の抗腫瘍/前腫瘍 dual roles が微小環境シグナルで連続的に切り替わる像が固まった (Hedrick et al. NatRevImmunol 2022 / Yu et al. Oncogene 2024)。

IO 効果と myeloid 微小環境の交絡も連続的に解明された。血清 IL-8 高値は腫瘍内好中球増加と ICI 不応を予測し (Schalper et al. NatMed 2020)、逆に IO 奏効時には IL-12 誘導の Sell-hi ISG (interferon-stimulated gene) 好中球応答が腫瘍制御と相関し (Gungabeesoon et al. Cell 2023)、腫瘍内在性 STING で誘導される Ly6E-hi IFN 刺激好中球は IL-12b を介して CD8+ T 細胞を活性化し、その NeutIFN-15 血液シグネチャは PD-L1 IHC (immunohistochemistry) や腫瘍変異量 (AUC 約 0.6-0.75) を上回る奏効予測能 (平均 AUC, area under the curve 約 0.9) を示した (Benguigui et al. CancerCell 2024)。治療標的としては CXCR1/2-NET 軸 (Teijeira et al. Immunity 2020) に加え、CXCR4 部分アゴニスト TFF2-MSA が免疫抑制性 Hdc+ PMN-MDSC を約 2 倍減らし癌駆動性 granulopoiesis を抑制して抗原提示性 C1 / 免疫抑制性 C2 好中球比を C1 優位へシフトさせ、抗 PD-1 と相乗して自然発生胃癌モデルの 80% を 300 日長期生存させた (Qian et al. CancerCell 2025)。

肺がん特異的には、STK11/LKB1 欠失が好中球動員と炎症性サイトカイン産生を介して T 細胞を抑制し IO 一次抵抗性に寄与すること (Koyama et al. CancerRes 2016)、好中球依存的な肺コロニー形成支援 (Wculek et al. Nature 2015)、肺間葉細胞が好中球に脂質を貯留させて乳癌肺転移を燃料供給すること (Li et al. NatImmunol 2020) が、driver mutation と pre-metastatic niche を myeloid を介して結びつけている。

治療概念は「TAN を抑制する」から「TAN を抗腫瘍方向へ再プログラムする」へ拡張しつつある。従来の阻害的アプローチ (DNase I / PAD4 / NE / CXCR1-2 / CD300ld / FATP2 inhibitor) に加え、IL-36γ を分泌する DLL3/GD3 デュアル armored CAR-T (chimeric antigen receptor T cell) は、リンパ球枯渇前処置なしで腫瘍内好中球を腫瘍殺傷性かつ MHC (major histocompatibility complex) クラス I/II を介した抗原提示性へ再教育し、エピトープ拡散によって CAR 標的以外の抗原を認識する内因性 T 細胞記憶を確立して抗原陰性腫瘍の再チャレンジを拒絶した (Zuo et al. CancerCell 2026)。この好中球依存性は抗 Ly6G 抗体による好中球枯渇で治療効果が完全消失することで裏づけられ、「armored CAR-T → 好中球の再プログラム化 → 内因性抗がん免疫サイクル」という myeloid–CAR-T クロストーク設計が固形腫瘍細胞療法の新たな設計原則となりつつある。

主要エンティティ

薬剤クラス (IO context)

PD-1-inhibitor / PD-L1-inhibitor / CTLA-4-inhibitor — IL-8 / CXCR1-2 軸経由の好中球-IO interaction (Schalper et al. NatMed 2020)

(Phase B 拡張候補: CXCR1/2 inhibitor / PAD4 inhibitor / NE inhibitor / FATP2 inhibitor / CD300ld inhibitor 等)

主要概念

NETosis-cancer-metastasis — NET-CCDC25 軸、CTC trapping、休眠覚醒の central mechanism
Pre-metastatic-niche — 好中球動員と臓器親和性 (PMN 形成における neutrophil の central role)
Cancer-dormancy — NET-mediated awakening、化療誘発 NET → TGF-β → 治療抵抗性
irAE-pathophysiology — IL-8/myeloid 軸 ↔ ICI 効果、CXCR1/2 inhibitor + IO rationale

(Phase D 拡張候補: N1/N2 polarization paradigm / MDSC heterogeneity / NETosis-IO interaction / IL-8/CXCR1-2 axis / emergency granulopoiesis)

Open Questions

単細胞分類の統合的合意：4 層 roadmap (Ng et al. Immunity 2025) と種横断的 SELL-hi → CCL3-hi 軌跡 (Bolli et al. CancerCell 2026) は提案されたが、organ・cancer 横断で再現可能な neutrophil ontology と堅牢な運命マッピング法の標準化は未確立
NET 治療標的化の臨床応用：DNase I・PAD4 (BMS-P5 / JBI-589)・NE (sivelestat)・脱シアル化酵素 (E-602) の anti-metastatic / 抗再発効果は前臨床で robust だが、出血・感染リスクとの benefit-risk と phase II/III エビデンスは未到達。化学療法後の線維芽細胞老化-SASP-NETosis カスケード (He et al. CancerCell 2025) を捉える循環バイオマーカー (C3 / MIF / cit-H3) と、セノリティクス / NET 阻害の至適併用タイミングもヒトで未検証
抗原提示性 TAN の臨床的意義：HLA-DR+ / 再プログラム好中球が誘導する内因性 T 細胞応答が臨床奏効に寄与する程度と、SOX2-FADS1/PGE2 による近傍 TAN 抑制 (Guo et al. CancerCell 2026) を解除して抗腫瘍状態を安定誘導する条件は不明
免疫抑制ハブの標的選択：CD300ld-ホスファチジルセリン軸・CCL3-CCR1-Bcl2a・FADS1/PGE2 のうち臨床第 I 相に進む標的と適応疾患、抗 PD-1 併用での上乗せ幅 (CD300ld 中和は MC38 で CR 60% の前臨床根拠) は未確定
IO 効果予測 myeloid biomarker：IL-8、Ly6E-hi/ISG (NeutIFN-15) 好中球シグネチャ、CCL3 シグネチャの中で臨床実装可能な閾値・アッセイ標準化と、免疫療法 vs 標準治療での予後/予測の使い分けは未決
好中球再プログラム細胞療法の一般化：IL-36γ armored CAR-T の cold tumor / 多癌種への汎用性、IL-36γ 全身毒性、誘導された内因性免疫記憶の持続期間は今後の検証課題

重要論文 Top 10

★★★★★ Yang et al. Nature 2020 — NET-DNA を感知する CCDC25 受容体を同定、転移臓器指向性の分子基盤
★★★★★ Albrengues et al. Science 2018 — NE/MMP9 による laminin 切断 → integrin α3β1 活性化で休眠覚醒
★★★★★ Wculek et al. Nature 2015 — 好中球依存的 pre-metastatic niche 形成の reference
★★★★★ Salcher et al. CancerCell 2022 — NSCLC 好中球 scRNA atlas、N1/N2 二分法を超越
★★★★★ Schalper et al. NatMed 2020 — IL-8/好中球軸 ICI biomarker、CXCR1/2 阻害開発の論拠
★★★★★ Koyama et al. CancerRes 2016 — STK11 LOF → 好中球動員 → T 細胞抑制 (IO 抵抗性 link)
★★★★ Gungabeesoon et al. Cell 2023 — IO 応答性の好中球シグネチャ — IL-12 induced anti-tumor neutrophils
★★★★ Veglia et al. NatRevImmunol 2021 — MDSC heterogeneity 再概念化 (現代 myeloid biology)
★★★★ Adrover et al. CancerCell 2023 — NET-cancer bidirectional interplay 統合 review
★★★★ Mousset et al. CancerCell 2023 — 化療誘発 NET → TGF-β → 治療抵抗性

最新追加論文 Top 10

Routy et al. Science 2018 — Basic-Immunotherapy
Fuchs et al. ProcNatlAcadSciUSA 2010 — Basic-Neutrophil and myeloid cell
Gabrilovich et al. NatRevImmunol 2012 — Basic-Neutrophil and myeloid cell
Wu et al. JImmunotherCancer 2026 — Basic-Immunotherapy
George et al. CancerRes 2026 — Basic-Immunotherapy
Hao et al. CellRepMed 2026 — Basic-Neutrophil and myeloid cell
Morrissey et al. eLife 2018 — Basic-Immunotherapy
Rys et al. TrendsCellBiol 2025 — Basic-Neutrophil and myeloid cell
Yue et al. Cell 2026 — Basic-Immunotherapy
Lin et al. JImmunotherCancer 2026 — Basic-Neutrophil and myeloid cell

全論文リスト (カテゴリ別、自動生成)

Basic-Immunotherapy

Wiest et al. BrJCancer 2026 — Differential effects of prior versus concomitant steroid and antibiotic treatment on immunotherapy efficacy-A pooled
Foidart et al. CancerCell 2026 — Whole-genome doubling drives immune evasion by silencing antigen presentation
Karakousi et al. CancerCell 2026 — IFNgamma-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
Kureshi et al. CancerCell 2026 — Dendritic cell redundancy enables priming of anti-tumor cd4+ t cells in pancreatic cancer
Liu et al. CancerCell 2026 — Clonal lineage tracing of innate immune cells in human cancer
Molina-Arcas et al. CancerDiscov 2026 — Sensitizing lung cancer to immunotherapy with a RAS(ON) inhibitor doublet
Pinto et al. CancerGeneTher 2026 — Preclinical development of a mutant KRAS targeting therapeutic cancer vaccine
Kamigaichi et al. CancerImmunolImmunother 2026 — Immunological impact of tumor-draining lymph node dissection on systemic th1-like CD4+ T cells in patients with
George et al. CancerRes 2026 — Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8…
Brown et al. Cell 2026 — Gut microbiota promotes immune tolerance at the maternal-fetal interface
Chemla et al. Cell 2026 — HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion
Davar et al. Cell 2026 — Improving immunotherapy in solid tumors using FMT
Heieis et al. Cell 2026 — O-glcnacylation drives macrophage IL-4 responsiveness and tissue residency through metabolic and cell cycle calibration
Marine et al. Cell 2026 — Mapping intratumor heterogeneity across layers for advancing immunotherapy
Scharping et al. Cell 2026 — Proteostasis sustains t cell differentiation potential and tumor-infiltrating lymphocyte function
Wang et al. Cell 2026 — A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers
Wang et al. Cell 2026 — CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
Yue et al. Cell 2026 — Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy
Zhang et al. Cell 2026 — A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR t cell therapy
Chen et al. CellMetab 2026 — 16-h fasting optimizes cancer immunotherapy in mice and humans
Nutt et al. CellMolImmunol 2026 — Defining the rules of engagement b cells, antibodies and cancer control
Cremasco et al. CellRep 2026 — Natural killer cells swarm and cross-recruit cytotoxic T cells via CCR5
Ma et al. CellRep 2026 — Multivalent nanoparticles activate t-dependent antibody response via antigen presentation by both b cells and dendritic
Brennan et al. CellRepMed 2026 — Circulating natural killer cells are phenotypically and functionally altered in age-related macular degeneration
Jung et al. FrontImmunol 2026 — ATG5-mediated inducible autophagy sustains CAR-T cell durability under solid tumor stress
Mao et al. FrontImmunol 2026 — MicroRNA-targeted reprogramming of CD8+ T cells against cancer
Smesseim et al. FrontMed(Lausanne) 2026 — Defining the abscopal effect in non-small cell lung cancer in the era of immunotherapy and lung ablation treatment a
Pei et al. Immunity 2026 — Neutrophil regulation of immunotherapy for cancer is controlled by type II interferon
Aires-Lopes et al. ImmunolCellBiol 2026 — Highlights of 2025 advancements in natural killer cell biology
Bansal et al. JCOPrecisOncol 2026 — Immunotherapy response and survival outcome by immunophenotypic signature in non-small cell lung cancer
Lopez-Janeiro et al. JClinInvest 2026 — Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer
Akbar et al. JImmunol 2026 — Myelin antigen-specific effector CD8+ T cells induce chronic CNS autoimmunity in a CD4+ T cell-dependent manner
Carreira et al. JImmunotherCancer 2026 — CXCR3 signaling promotes delta one T cell recruitment and antitumor efficacy in colorectal cancer
Gonzalez et al. JImmunotherCancer 2026 — Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer
Keddar et al. JImmunotherCancer 2026 — Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy
Wu et al. JImmunotherCancer 2026 — Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39
Zhang et al. JNanobiotechnology 2026 — Apigenin based nanoplatform achieves non-small cell lung cancer immunotherapy through glycolysis inhibition and
Huang et al. NatBiomedEng 2026 — Programmable mRNA 3utr engineering restores MHC-I and overcomes immune evasion in prostate cancer
Gupta et al. NatBiotechnol 2026 — Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models
Bernstock et al. NatCancer 2026 — Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment
Melero et al. NatCancer 2026 — Safety and activity of ro7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with
Steeghs et al. NatCancer 2026 — Tumor-localized CD40 agonism with mp0317, a FAP x CD40 darpin, reprograms the tumor microenvironment in patients with
Wang et al. NatCellBiol 2026 — Slc2a1+ tumour-associated macrophages spatially control cd8+ t cell function and drive resistance to immunotherapy in
Ito et al. NatCommun 2026 — Phenotype of circulating tumor-reactive t cells predicts immune checkpoint inhibitor response in non-small cell lung
Kim et al. NatImmunol 2026 — Engineering NK and T cells with metabolite-sensing receptors to target solid tumors
Pires et al. NatMater 2026 — IL-12-releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer
Gonzalez-Kozlova et al. NatMed 2026 — Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
Lu et al. NatRevCancer 2026 — Opportunities and challenges of targeting cGAS-STING in cancer
Bianca et al. NatRevImmunol 2026 — CRISPR screen reveals regulators of age-associated cd8+ t cell dysfunction in cancer
Elahi et al. NatRevImmunol 2026 — Immune regulation by erythroid cells how erythroid progenitor cells and mature red blood cells shape immunity
Sinha et al. NatRevImmunol 2026 — O-glcnacylation shapes macrophage tissue residency and alternative activation
Cassandras et al. Nature 2026 — A glucocorticoid-FAS axis controls immune evasion during metastatic seeding
Kumar et al. Nature 2026 — Postprandial lipid metabolism durably enhances t cell immunity
Li et al. Nature 2026 — SLAMF6 as a drug-targetable suppressor of t cell immunity against cancer
Medina et al. Nature 2026 — Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion
Nicola et al. Nature 2026 — Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity
Robay et al. ProcNatlAcadSciUSA 2026 — Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy
Yuan et al. ProcNatlAcadSciUSA 2026 — Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge
Corrigan et al. SciImmunol 2026 — In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs
Li et al. SciImmunol 2026 — Citraconate preserves T cell stemness and antitumor immunity
Wei et al. SciImmunol 2026 — Foxp3 drives context-dependent epigenetic programs that define regulatory t cell molecular identity and function
Cohen et al. SciTranslMed 2026 — Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune
Merkt et al. SciTranslMed 2026 — Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts
Zhou et al. Science 2026 — Intermetallic nanoassemblies potentiate systemic STING activation
Chakraborty et al. SignalTransductTargetTher 2026 — Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer
Chung et al. SignalTransductTargetTher 2026 — Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy
Dietze et al. SignalTransductTargetTher 2026 — Preventing trogocytosis by cathepsin b inhibition augments CAR t-cell function
Slater et al. TrendsCancer 2026 — Epigenetic, epitranscriptomic, and metabolic control of t cell exhaustion
Kundu et al. BiolMethodsProtoc 2025 — Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applic…
Zhang et al. Cell 2025 — Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance
Pitter et al. JClinInvest 2025 — Citrullination in tumor immunity and therapy
Gong et al. Nature 2025 — Multi-omic profiling reveals age-related immune dynamics in healthy adults
Ikeda et al. Nature 2025 — Immune evasion through mitochondrial transfer in the tumour microenvironment
Chang et al. STARProtoc 2025 — Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy
Galassi et al. CancerCell 2024 — The hallmarks of cancer immune evasion
McGinnis et al. CancerCell 2024 — The temporal progression of lung immune remodeling during breast cancer metastasis
Petralia et al. Cell 2024 — Pan-cancer proteogenomics characterization of tumor immunity
Pozniak et al. Cell 2024 — A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma
Wang et al. NatMetab 2024 — Acetate reprogrammes tumour metabolism and promotes PD-l1 expression and immune evasion by upregulating c-Myc
Ascic et al. Science 2024 — In vivo dendritic cell reprogramming for cancer immunotherapy
Vennin et al. CancerCell 2023 — Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
Zhu et al. CancerCell 2023 — Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high
Sharma et al. Cell 2023 — Immune checkpoint therapy-current perspectives and future directions
Lerner et al. NatCancer 2023 — CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis
Ravi et al. NatGenet 2023 — Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Chu et al. NatMed 2023 — Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Puig-Saus et al. Nature 2023 — Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
Reina-Campos et al. Nature 2023 — Metabolic programs of T cell tissue residency empower tumour immunity
Rojas et al. Nature 2023 — Personalized RNA neoantigen vaccines stimulate t cells in pancreatic cancer
Sender et al. ProcNatlAcadSciUSA 2023 — The total mass, number, and distribution of immune cells in the human body
Quigley et al. STARProtoc 2023 — Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal-TSA mult…
Kitajima et al. CancerCell 2022 — MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Nassar et al. CancerCell 2022 — Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune
Tang et al. CancerDiscov 2022 — Combined inhibition of SHP2 and CXCR12 promotes antitumor T-cell response in NSCLC
Combes et al. Cell 2022 — Discovering dominant tumor immune archetypes in a pan-cancer census
Luoma et al. Cell 2022 — Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
Marzio et al. Cell 2022 — EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion
Sellars et al. Cell 2022 — Cancer vaccines Building a bridge over troubled waters
Best et al. CellMetab 2022 — Glutaminase inhibition impairs CD8 T cell activation in STK11-lkb1-deficient lung cancer
Kos et al. CellRep 2022 — Tumor-educated tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche
Hollmen et al. MolCancerTher 2022 — Nonclinical characterization of bexmarilimab, a clever-1-targeting antibody for supporting immune defense against
Chong et al. NatBiotechnol 2022 — Identification of tumor antigens with immunopeptidomics
Nishiga et al. NatCancer 2022 — Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Lee et al. NatImmunol 2022 — Significance of bystander T cell activation in microbial infection
Liu et al. NatImmunol 2022 — tRNA-m1A modification promotes T cell expansion via efficient MYC protein synthesis
Kraehenbuehl et al. NatRevClinOncol 2022 — Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Hong et al. Nature 2022 — Immune tolerance of food is mediated by layers of CD4+ T cell dysfunction
Legut et al. Nature 2022 — A genome-scale screen for synthetic drivers of T cell proliferation
Kvedaraite et al. SciImmunol 2022 — Human dendritic cells in cancer
Oja et al. SciImmunol 2022 — Two sides of the same coin protective versus pathogenic CD4+ resident memory T cells
Lowery et al. Science 2022 — Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
Ritter et al. Science 2022 — ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack
Koya et al. BloodCancerDiscov 2021 — Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1
Bagati et al. CancerCell 2021 — Integrin avb6-TGFb-SOX4 pathway drives immne evasion in TNBC
Chow et al. CancerCell 2021 — Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
Lin et al. CancerCell 2021 — Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance
Kumar et al. CancerDiscov 2021 — CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells
Mahadevan et al. CancerDiscov 2021 — Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity
Montesion et al. CancerDiscov 2021 — Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden
Pore et al. CancerDiscov 2021 — Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional STK11 mutations in patients
Veneziani et al. CancerImmunolRes 2021 — Nutlin-3a enhances natural killer cell-mediated killing of neuroblastoma by restoring p53-dependent expression of
Yang et al. CancerImmunolRes 2021 — Targeted deletion of CXCR2 in myeloid cells alters the tumor immune environment to improve antitumor immunity
Burger et al. Cell 2021 — Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors
DiPilato et al. Cell 2021 — CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
Litchfield et al. Cell 2021 — Meta-analysis of tumor-and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Chalfin et al. ClinCancerRes 2021 — Circulating tumor cell subtypes and T-cell populations as prognostic biomarkers to combination immunotherapy in
Datar et al. ClinCancerRes 2021 — Spatial analysis and clinical significance of HLA class-I and class-II subunit expression in non-small cell lung cancer
Jou et al. ClinCancerRes 2021 — The changing landscape of therapeutic cancer vaccines-novel platforms and neoantigen identification
Virtakoivu et al. ClinCancerRes 2021 — Systemic blockade of clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients
Ozga et al. Immunity 2021 — Chemokines and the immune response to cancer
Baretti et al. JClinInvest 2021 — Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacy
Lhuillier et al. JClinInvest 2021 — Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
Sehgal et al. JClinInvest 2021 — Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
Olson et al. JClinOncol 2021 — Pembrolizumab plus ipilimumab following anti-PD-1l1 failure in melanoma
Meric-Bernstam et al. Lancet 2021 — Enhancing anti-tumour efficacy with immunotherapy combinations
Dileepan et al. NatBiotechnol 2021 — MHC class II tetramers engineered for enhanced binding to CD4 improve detection of antigen-specific T cells
Sugata et al. NatBiotechnol 2021 — Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells
Kim et al. NatCommun 2021 — CD177 modulates the function and homeostasis of tumor-infiltrating regulatory t cells
Valpione et al. NatCommun 2021 — The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
Labarta-Bajo et al. NatImmunol 2021 — BAtCHing stem-like T cells during exhaustion
Liu et al. NatImmunol 2021 — Mitochondria orchestrate T cell fate and function
Lopes et al. NatImmunol 2021 — Distinct metabolic programs established in the thymus control effector functions of gammadelta T cell subsets in tumor
Liu et al. NatMed 2021 — Evolution of delayed resistance to immunotherapy in a melanoma responder
Powles et al. NatMed 2021 — An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced
Bayik et al. NatRevCancer 2021 — Cancer stem cell-immune cell crosstalk in tumour progression
Chabanon et al. NatRevCancer 2021 — Targeting the DNA damage response in immuno-oncology developments and opportunities
Jhunjhunwala et al. NatRevCancer 2021 — Antigen presentation in cancer insights into tumour immunogenicity and immune evasion
Hou et al. NatRevClinOncol 2021 — Targeting cancer-promoting inflammation-have anti-inflammatory therapies come of age
LopezDeRodas et al. NatRevClinOncol 2021 — Tumour antigen-induced T cell exhaustion-the archenemy of immune-hot malignancies
Caushi et al. Nature 2021 — Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Hellmeier et al. ProcNatlAcadSciUSA 2021 — DNA origami demonstrate the unique stimulatory power of single pMHCs as T cell antigens
Han et al. SciAdv 2021 — Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung
Watson et al. SciImmunol 2021 — Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size
Foord et al. SciTranslMed 2021 — Characterization of ascites-and tumor-infiltrating gammadelta T cells reveals distinct repertoires and a beneficial
Shen et al. SciTranslMed 2021 — LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Davar et al. Science 2021 — Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Hsiue et al. Science 2021 — Targeting a neoantigen derived from a common TP53 mutation
Spencer et al. Science 2021 — Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Xu et al. Science 2021 — Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
Zheng et al. Science 2021 — Pan-cancer single-cell landscape of tumor-infiltrating T cells
Leko et al. CancerCell 2020 — Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors
Motzer et al. CancerCell 2020 — Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Schoenfeld et al. CancerCell 2020 — Acquired resistance to immune checkpoint inhibitors
Hakozaki et al. CancerImmunolRes 2020 — The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non-small cell lung
Kortekaas et al. CancerImmunolRes 2020 — CD39 identifies the CD4+ tumor-specific T-cell population in human cancer
Kotanides et al. CancerImmunolRes 2020 — Bispecific targeting of PD-1 and PD-L1 enhances T-cell activation and antitumor immunity
Buggert et al. Cell 2020 — The identity of human tissue-emigrant CD8+ T cells
Jiang et al. Cell 2020 — Direct tumor killing and immunotherapy through anti-serpinB9 therapy
Liu et al. Cell 2020 — Detecting tumor antigen-specific T cells via interaction-dependent fucosyl-biotinylation
Ringel et al. Cell 2020 — Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity
Wells et al. Cell 2020 — Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
Malekzadeh et al. ClinCancerRes 2020 — Antigen experienced T cells from peripheral blood recognize p53 neoantigens
Olivera et al. ClinCancerRes 2020 — Exploiting TCR recognition of shared hotspot oncogene-encoded neoantigens
Proia et al. ClinCancerRes 2020 — STAT3 antisense oligonucleotide remodels the suppressive tumor microenvironment to enhance immune activation in
Zugazagoitia et al. ClinCancerRes 2020 — Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small cell lung cancer (NSCLC) identified using
Binder et al. FrontImmunol 2020 — CD2 immunobiology
Beltra et al. Immunity 2020 — Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic
Bilate et al. Immunity 2020 — T cell receptor is required for differentiation, but not maintenance, of intestinal CD4+ intraepithelial lymphocytes
Braun et al. Immunity 2020 — CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in
Weulersse et al. Immunity 2020 — Eomes-dependent loss of the co-activating receptor CD226 restrains CD8+ T cell anti-tumor functions and limits the
Li et al. JClinInvest 2020 — Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
Theivanthiran et al. JClinInvest 2020 — A tumor intrinsic PD-L1-LLRP3 inflamasome signaling pathway drives resistance to anti-PD-1 immunotherapy
Tanaka et al. JExpMed 2020 — Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
Honda et al. MolTher 2020 — Sustainable tumor-suppressive effect of iPSC-derived rejuvenated T cells targeting cervical cancers
Dolgin et al. NatBiotechnol 2020 — Antibody engineers seek optimal drug targeting TIGIT checkpoint
Reuben et al. NatCommun 2020 — Comprehensive T cell repertoire characterization of non-small cell lung cancer
Lakatos et al. NatGenet 2020 — Evolutionary dynamics of neoantigens in growing tumors
Aksoylar et al. NatImmunol 2020 — PD-1+ treg cells a foe in cancer immunotherapy
Bonaguro et al. NatImmunol 2020 — CRELD1 modulates homeostasis of the immune system in mice and humans
Kumagai et al. NatImmunol 2020 — The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade
Fairfax et al. NatMed 2020 — Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with
Laughney et al. NatMed 2020 — Regenerative lineages and immune-mediated pruning in lung cancer metastasis
Yofe et al. NatMed 2020 — Single-cell genomic approaches for developing the next generation of immunotherapies
Bruni et al. NatRevCancer 2020 — The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy
vanDerLeun et al. NatRevCancer 2020 — CD8+ T cell states in human cancer insights from single-cell analysis
Hogg et al. NatRevDrugDiscov 2020 — Targeting the epigenetic regulation of antitumour immunity
Lawson et al. Nature 2020 — Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
Lee et al. SciImmunol 2020 — Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
Ambler et al. SciSignal 2020 — PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor
Hao et al. SciTranslMed 2020 — Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy
Kalbasi et al. SciTranslMed 2020 — Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in
Balint et al. Science 2020 — Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells
Topalian et al. Science 2020 — Neoadjuvant checkpoint blockade for cancer immunotherapy
Hammer et al. AnnuRevImmunol 2019 — Origin, organization, dynamics, and function of actin and actomyosin networks at the T cell immunological synapse
Burr et al. CancerCell 2019 — An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables im…
Wang et al. Cell 2019 — Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Cassioli et al. Cells 2019 — A ciliary view of the immunological synapse
Costa-Nunes et al. ClinCancerRes 2019 — High-throughput screening of human tumor antigen-specific CD4 T cells, including neoantigen-reactive T cells
Luke et al. ClinCancerRes 2019 — WNT beta-catenin pathway activation correlates with immune exclusion across human cancers
Viitala et al. ClinCancerRes 2019 — Immunotherapeutic blockade of macrophage clever-1 reactivates the CD8+ T-cell response against immunosuppressive tumors
Abelin et al. Immunity 2019 — Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction
VanDerVeeken et al. Immunity 2019 — Natural genetic variation reveals key features of epigenetic and transcriptional memory in virus-specific CD8 T cells
Goyette et al. JCellSci 2019 — How does T cell receptor clustering impact on signal transduction
Kamiya et al. JClinInvest 2019 — Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Nambiar et al. JClinInvest 2019 — Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
Duan et al. MolCancer 2019 — Natural killer group 2d receptor and its ligands in cancer immune escape
Mann et al. NatImmunol 2019 — Tick-TOX, it’s time for T cell exhaustion
Chowdhury et al. NatMed 2019 — Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Yost et al. NatMed 2019 — Clonal replacement of tumor-specific T cells following PD-1 blockade
Feng et al. NatRevCancer 2019 — Phagocytosis checkpoints as new targets for cancer immunotherapy
Havel et al. NatRevCancer 2019 — The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Esterhazy et al. Nature 2019 — Compartmentalized gut lymph node drainage dictates adaptive immune responses
Ishizuka et al. Nature 2019 — Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Khan et al. Nature 2019 — TOX transcriptionally and epigenetically programs CD8 T cell exhaustion
Rosenthal et al. Nature 2019 — Neoantigen-directed immune escape in lung cancer evolution
Tanoue et al. Nature 2019 — A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Kamada et al. ProcNatlAcadSciUSA 2019 — PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Ishihara et al. SciTranslMed 2019 — Targeted antibody and cytokine cancer immunotherapies through collagen affinity
Vodnala et al. Science 2019 — T cell stemness and dysfunction in tumors are triggered by a common mechanism
Minervina et al. TransplInt 2019 — T-cell receptor and B-cell receptor repertoire profiling in adaptive immunity
Hellmann et al. CancerCell 2018 — Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
Kitajima et al. CancerCell 2018 — Overcoming resistance to dual innate immune and MEK inhibition downstream of KRAS
Zappasodi et al. CancerCell 2018 — Non-conventional inhibitory CD4+Foxp3-PD-1hi T cells as a biomarker of immune checkpoint blockade activity
Chapman et al. CancerImmunolRes 2018 — Hallmarks of T-cell exit from quiescence
Andre et al. Cell 2018 — Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Azizi et al. Cell 2018 — Single-cell map of diverse immune phenotypes in the breast tumor microenvironment
Jerby-Arnon et al. Cell 2018 — A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
Mitroulis et al. Cell 2018 — Modulation of myelopoiesis progenitors is an integral component of trained immunity
Neal et al. Cell 2018 — Organoid Modeling of the Tumor Immune Microenvironment
Pyke et al. Cell 2018 — Evolutionary Pressure against MHC Class II Binding Cancer Mutations
Sade-Feldman et al. Cell 2018 — Defining T cell states associated with response to checkpoint immunotherapy in melanoma
Mazzaschi et al. ClinCancerRes 2018 — Low PD-1 expression in cytotoxic CD8+ tumor-infiltrating lymphocytes confers an immune-privileged tissue
Niknam et al. ClinCancerRes 2018 — Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor
Garris et al. Immunity 2018 — Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-gamma
Patel et al. Immunity 2018 — Combination cancer therapy with immune checkpoint blockade mechanisms and strategies
Sun et al. Immunity 2018 — Regulation and function of the PD-L1 checkpoint
Thorsson et al. Immunity 2018 — The immune landscape of cancer
Blery et al. JImmunol 2018 — NKG2D-MICA interaction A paradigm shift in innate recognition
Bentzen et al. NatBiotechnol 2018 — T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of
Gettinger et al. NatCommun 2018 — A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
Brameshuber et al. NatImmunol 2018 — Monomeric TCRs drive T cell antigen recognition
Barry et al. NatMed 2018 — A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Binnewies et al. NatMed 2018 — Understanding the tumor immune microenvironment (TIME) for effective therapy
Formenti et al. NatMed 2018 — Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Krieg et al. NatMed 2018 — High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
Savas et al. NatMed 2018 — Single cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved progn…
Thommen et al. NatMed 2018 — A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung
Haag et al. Nature 2018 — Targeting STING with covalent small-molecule inhibitors
Mariathasan et al. Nature 2018 — TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Chen et al. ProcNatlAcadSciUSA 2018 — B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction
Wang et al. ProcNatlAcadSciUSA 2018 — Adjuvant effect of the novel TLR1TLR2 agonist diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice
Chowell et al. Science 2018 — Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Ribas et al. Science 2018 — Cancer immunotherapy using checkpoint blockade
Routy et al. Science 2018 — Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Ruscetti et al. Science 2018 — NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Morrissey et al. eLife 2018 — Chimeric antigen receptors that trigger phagocytosis
Konagai et al. AnticancerRes 2017 — Correlation between NKG2DL expression and antitumor effect of protein-bound polysaccharide-K in tumor-bearing mouse
Gettinger et al. CancerDiscov 2017 — Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint
Reuben et al. CancerDiscov 2017 — TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas an association with predicted neoantigen
Shin et al. CancerDiscov 2017 — Primary resistance to PD-1 blockade mediated by JAK12 mutations
Scharping et al. CancerImmunolRes 2017 — Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia
Prat et al. CancerRes 2017 — Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous
Inoue et al. CancerSci 2017 — Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer
Lavin et al. Cell 2017 — Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses
Marty et al. Cell 2017 — MHC-I genotype restricts the oncogenic mutational landscape
McGranahan et al. Cell 2017 — Allele-specific HLA loss and immune escape in lung cancer evolution
Nissim et al. Cell 2017 — Synthetic RNA-based immunomodulatory gene circuits for cancer immunotherapy
Riaz et al. Cell 2017 — Tumor and microenvironment evolution during immunotherapy with nivolumab
Sharma et al. Cell 2017 — Primary, adaptive, and acquired resistance to cancer immunotherapy
Spitzer et al. Cell 2017 — Systemic immunity is required for effective cancer immunotherapy
Topper et al. Cell 2017 — Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer
Garcia-Diaz et al. CellRep 2017 — Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression
Kim et al. EurJCancer 2017 — Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas
Garrido et al. FrontPharmacol 2017 — Upregulation of HLA class I expression on tumor cells by the anti-EGFR antibody nimotuzumab
Mazorra et al. FrontPharmacol 2017 — Nimotuzumab induces NK cell activation, cytotoxicity, dendritic cell maturation and expansion of EGFR-specific T cells
Ayers et al. JClinInvest 2017 — IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade
Faruki et al. JThoracOncol 2017 — Lung adenocarcinoma and squamous cell carcinoma gene expression subtypes demonstrate significant differences in tumor
Turajlic et al. LancetOncol 2017 — Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype a pan-cancer analysis
Sade-Feldman et al. NatCommun 2017 — Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Weichselbaum et al. NatRevClinOncol 2017 — Radiotherapy and immunotherapy a beneficial liaison
Burr et al. Nature 2017 — CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Chen et al. Nature 2017 — Elements of cancer immunity and the cancer-immune set point
Huang et al. Nature 2017 — T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Luksza et al. Nature 2017 — A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Manguso et al. Nature 2017 — In vivo CRISPR screening identifies ptpn2 as a cancer immunotherapy target
Patel et al. Nature 2017 — Identification of essential genes for cancer immunotherapy
Sahin et al. Nature 2017 — Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Wang et al. Oncogene 2017 — BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFRMAPK signaling pathways in non-small cell
Chen et al. Oncotarget 2017 — Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers
Allen et al. SciTranslMed 2017 — Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation
Davoli et al. Science 2017 — Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Hui et al. Science 2017 — T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
LeDung et al. Science 2017 — Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Stubbington et al. Science 2017 — Single-cell transcriptomics to explore the immune system in health and disease
Inaguma et al. AmJSurgPathol 2016 — Comprehensive immunohistochemical study of programmed cell death ligand 1 (PD-L1) analysis in 5536 cases revealed
Kim et al. BrJCancer 2016 — Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
Liu et al. CancerDiscov 2016 — Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease
Peng et al. CancerDiscov 2016 — Loss of PTEN promotes resistance to T cell-mediated immunotherapy
Zah et al. CancerImmunolRes 2016 — T cells expressing CD19CD20 bispecific chimeric antigen receptors prevent antigen escape by malignant B cells
Housseau et al. CancerRes 2016 — Redundant innate and adaptive sources of IL17 production drive colon tumorigenesis
Gao et al. Cell 2016 — Loss of IFN-pathway genes in tumor cells as a mechanism of resistance to anti-ctla-4 therapy
Hugo et al. Cell 2016 — Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma
Malladi et al. Cell 2016 — Metastatic latency and immune evasion through autocrine inhibition of WNT
Minn et al. Cell 2016 — Combination cancer therapies with immune checkpoint blockade convergence on interferon signaling
Palucka et al. Cell 2016 — The basis of oncoimmunology
Giannakis et al. CellRep 2016 — Genomic correlates of immune-cell infiltrates in colorectal carcinoma
Maus et al. ClinCancerRes 2016 — Making better chimeric antigen receptors for adoptive T-cell therapy
Anderson et al. Immunity 2016 — Lag-3, tim-3, and TIGIT co-inhibitory receptors with specialized functions in immune regulation
Mlecnik et al. Immunity 2016 — Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than
Pitt et al. Immunity 2016 — Resistance mechanisms to immune-checkpoint blockade in cancer tumor-intrinsic and-extrinsic factors
McLaughlin et al. JAMAOncol 2016 — Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer
Lizotte et al. JCIInsight 2016 — Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes
Yu et al. JThoracOncol 2016 — PD-L1 expression in lung cancer
Rosenbaum et al. ModPathol 2016 — PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary
Zaretsky et al. NEnglJMed 2016 — Mutations associated with acquired resistance to PD-1 blockade in melanoma
Koyama et al. NatCommun 2016 — Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Riaz et al. NatGenet 2016 — Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy
Moro et al. NatImmunol 2016 — Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses
Moynihan et al. NatMed 2016 — Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune
Pozzi et al. NatMed 2016 — The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
Saito et al. NatMed 2016 — Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers
Topalian et al. NatRevCancer 2016 — Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Romero et al. NatRevClinOncol 2016 — Immunotherapy PD-1 says goodbye, TIM-3 says hello
Im et al. Nature 2016 — Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Yang et al. Nature 2016 — Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism
Hernandez et al. Oncogene 2016 — Damage-associated molecular patterns in cancer a double-edged sword
Lin et al. Oncotarget 2016 — The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression a pooled analysis of
Blank et al. Science 2016 — CANCER IMMUNOLOGY. the cancer immunogram
McGranahan et al. Science 2016 — Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Stronen et al. Science 2016 — Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Topalian et al. CancerCell 2015 — Immune checkpoint blockade a common denominator approach to cancer therapy
Lanier et al. CancerImmunolRes 2015 — NKG2D receptor and its ligands in host defense
Liadi et al. CancerImmunolRes 2015 — Individual motile CD4(+) T cells can participate in efficient multikilling through conjugation to multiple tumor cells
Severson et al. CancerImmunolRes 2015 — PD-1+tim-3+ CD8+ T lymphocytes display varied degrees of functional exhaustion in patients with regionally metastatic
Srivastava et al. CancerImmunolRes 2015 — STAT1-induced HLA class I upregulation enhances immunogenicity and clinical response to anti-EGFR mAb cetuximab therapy
Donia et al. CancerRes 2015 — Aberrant expression of MHC class II in melanoma attracts inflammatory tumor-specific CD4+ T-cells, which dampen CD8+
Chiappinelli et al. Cell 2015 — Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses
Rooney et al. Cell 2015 — Molecular and genetic properties of tumors associated with local immune cytolytic activity
Jiang et al. CellDeathDis 2015 — T-cell exhaustion in the tumor microenvironment
Zhai et al. ClinCancerRes 2015 — Molecular pathways targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy
Attaf et al. ClinExpImmunol 2015 — The T cell antigen receptor the swiss army knife of the immune system
Kitazono et al. ClinLungCancer 2015 — Reliability of small biopsy samples compared with resected specimens for the determination of programmed death-ligand 1
Zhang et al. FrontImmunol 2015 — NKG2D ligands in tumor immunity two sides of a coin
Demaria et al. JAMAOncol 2015 — Role of local radiation therapy in cancer immunotherapy
Chen et al. JClinInvest 2015 — Anti-PD-1pd-L1 therapy of human cancer past, present, and future
Melief et al. JClinInvest 2015 — Therapeutic cancer vaccines
Ilyas et al. JImmunol 2015 — Landscape of tumor antigens in T cell immunotherapy
Schalper et al. JNatlCancerInst 2015 — Objective measurement and clinical significance of TILs in non-small cell lung cancer
Ansell et al. NEnglJMed 2015 — PD-1 blockade with nivolumab in relapsed or refractory hodgkin’s lymphoma
Gentles et al. NatMed 2015 — The prognostic landscape of genes and infiltrating immune cells across human cancers
Wherry et al. NatRevImmunol 2015 — Molecular and cellular insights into T cell exhaustion
Kreiter et al. Nature 2015 — Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sabado et al. Nature 2015 — Cancer immunotherapy dendritic-cell vaccines on the move
Fu et al. SciTranslMed 2015 — STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Joyce et al. Science 2015 — T cell exclusion, immune privilege, and the tumor microenvironment
Rizvi et al. Science 2015 — Cancer immunology. mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Schumacher et al. Science 2015 — Neoantigens in cancer immunotherapy
Sharma et al. Science 2015 — The future of immune checkpoint therapy
Steinle et al. Science 2015 — Immunology. MULT1plying cancer immunity
Tran et al. Science 2015 — Immunogenicity of somatic mutations in human gastrointestinal cancers
VanAllen et al. Science 2015 — Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Cho et al. BMCCancer 2014 — MICAB and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
Dustin et al. CancerImmunolRes 2014 — The immunological synapse
Taube et al. ClinCancerRes 2014 — Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1
Fooksman et al. FrontImmunol 2014 — Organizing MHC class II presentation
Koh et al. JHepatol 2014 — Cancer immunotherapy targeting the difference
Gorman et al. JImmunol 2014 — Tim-3 directly enhances CD8 T cell responses to acute listeria monocytogenes infection
Velcheti et al. LabInvest 2014 — Programmed death ligand-1 expression in non-small cell lung cancer
Snyder et al. NEnglJMed 2014 — Genetic basis for clinical response to CTLA-4 blockade in melanoma
Farber et al. NatRevImmunol 2014 — Human memory T cells generation, compartmentalization and homeostasis
Speiser et al. NatRevImmunol 2014 — T cell differentiation in chronic infection and cancer functional adaptation or exhaustion
Gubin et al. Nature 2014 — Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Herbst et al. Nature 2014 — Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Nogrady et al. Nature 2014 — Immunotherapy chemical tricks
Powles et al. Nature 2014 — MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Tumeh et al. Nature 2014 — PD-1 blockade induces responses by inhibiting adaptive immune resistance
Qi et al. ProcNatlAcadSciUSA 2014 — Diversity and clonal selection in the human T-cell repertoire
Kvistborg et al. SciTranslMed 2014 — Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response
Vantourout et al. SciTranslMed 2014 — Immunological Visibility Posttranscriptional regulation of human NKG2DL by the EGFR receptor pathway
Kuehn et al. Science 2014 — Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Maeda et al. Science 2014 — Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals
Tran et al. Science 2014 — Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
Li et al. BioProtocol 2013 — Generation of mouse iNKT cell lines
Rech et al. CancerDiscov 2013 — Dynamic interplay of oncogenes and T cells induces PD-L1 in the tumor microenvironment
John et al. ClinCancerRes 2013 — Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells
Melief et al. ClinCancerRes 2013 — License to kill reflects joint action of CD4 and CD8 T cells
Chen et al. Immunity 2013 — Oncology meets immunology the cancer-immunity cycle
vanRooij et al. JClinOncol 2013 — Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma
Goding et al. JImmunol 2013 — Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma
Maiti et al. JImmunother 2013 — Sleeping beauty system to redirect T-cell specificity for human applications
Mkrtichyan et al. JImmunotherCancer 2013 — Anti-PD-1 antibody significantly increases therapeutic efficacy of listeria monocytogenes (lm)-LLO immunotherapy
Kloss et al. NatBiotechnol 2013 — Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Yoshihara et al. NatCommun 2013 — Inferring tumour purity and stromal and immune cell admixture from expression data
Okazaki et al. NatImmunol 2013 — A rheostat for immune responses the unique properties of PD-1 and their advantages for clinical application
Robbins et al. NatMed 2013 — Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Chen et al. NatRevImmunol 2013 — Molecular mechanisms of T cell co-stimulation and co-inhibition
Spranger et al. SciTranslMed 2013 — Up-regulation of PD-L1, IDO, and t(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells
delaRoche et al. Science 2013 — Hedgehog signaling controls T cell killing at the immunological synapse
Serbina et al. AdvImmunol 2012 — Monocyte-mediated immune defense against murine Listeria monocytogenes infection
Bilate et al. AnnuRevImmunol 2012 — Induced CD4+Foxp3+ regulatory T cells in immune tolerance
Olino et al. ArchSurg 2012 — Glycolipid antigens for treating hepatic colorectal cancer metastases and their effect on the therapeutic efficacy of
Bera et al. BiochemBiophysResCommun 2012 — POTE protein, a cancer-testis antigen, is highly expressed in spermatids in human testis and is associated with
Ribas et al. NEnglJMed 2012 — Tumor immunotherapy directed at PD-1
Fridman et al. NatRevCancer 2012 — The immune contexture in human tumours impact on clinical outcome
Pardoll et al. NatRevCancer 2012 — The blockade of immune checkpoints in cancer immunotherapy
Maecker et al. NatRevImmunol 2012 — Standardizing immunophenotyping for the human immunology project
Matsushita et al. Nature 2012 — Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Donia et al. ScandJImmunol 2012 — Characterization and comparison of ‘standard’ and ‘young’ tumour-infiltrating lymphocytes for adoptive cell therapy at
Taube et al. SciTranslMed 2012 — Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive
Wherry et al. NatImmunol 2011 — T cell exhaustion
Mellman et al. Nature 2011 — Cancer immunotherapy comes of age
Schreiber et al. Science 2011 — Cancer immunoediting integrating immunity’s roles in cancer suppression and promotion
Shrimali et al. CancerRes 2010 — Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive
Ramakrishnan et al. JClinInvest 2010 — Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Brahmer et al. JClinOncol 2010 — Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors safety, clinical activity,
Sakuishi et al. JExpMed 2010 — Targeting Tim-3 and PD-1 pathway to restore anti-tumor immunity
Goodnow et al. NatImmunol 2010 — Control systems and decision making for antibody production
Mueller et al. NatImmunol 2010 — Mechanisms maintaining peripheral tolerance
Moro et al. Nature 2010 — Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells
Curran et al. ProcNatlAcadSciUSA 2010 — PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16
Zhao et al. JImmunol 2009 — A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T
Ahmed et al. MolTher 2009 — Immunotherapy for osteosarcoma genetic modification of T cells overcomes low levels of tumor antigen expression
Wilson et al. NatRevImmunol 2009 — Epigenetic control of T-helper-cell differentiation
Ishikawa et al. Nature 2009 — STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Stavnezer et al. AnnuRevImmunol 2008 — Mechanism and regulation of class switch recombination
Burgess et al. ImmunolRes 2008 — The NKG2D receptor immunobiology and clinical implications
Zou et al. NatRevImmunol 2008 — Inhibitory B7-family molecules in the tumour microenvironment
Yoshimura et al. CancerRes 2007 — Live attenuated listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced
Vascotto et al. JCellBiol 2007 — The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation
Parsa et al. NatMed 2007 — Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Boon et al. AnnuRevImmunol 2006 — Human T cell responses against melanoma
Bera et al. CancerRes 2006 — POTE paralogs are induced and differentially expressed in many cancers
Yoshimura et al. CancerRes 2006 — Selective targeting of antitumor immune responses with engineered live-attenuated listeria monocytogenes
Barber et al. Nature 2006 — Restoring function in exhausted CD8 T cells during chronic viral infection
Galon et al. Science 2006 — Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Campi et al. JExpMed 2005 — Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling
Goodnow et al. Nature 2005 — Cellular and genetic mechanisms of self tolerance and autoimmunity
Raulet et al. NatRevImmunol 2003 — Roles of the NKG2D immunoreceptor and its ligands
Janeway et al. AnnuRevImmunol 2002 — Innate immune recognition
Dunn et al. NatImmunol 2002 — The three Es of cancer immunoediting
Freiberg et al. NatImmunol 2002 — Staging and resetting T cell activation in SMACs
Dong et al. NatMed 2002 — Tumor-associated B7-H1 promotes T-cell apoptosis a potential mechanism of immune evasion
Murphy et al. NatRevImmunol 2002 — The lineage decisions of helper T cells
Iwai et al. ProcNatlAcadSciUSA 2002 — Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Sutherland et al. ImmunolRev 2001 — The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell
Shankaran et al. Nature 2001 — IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Nishimura et al. Science 2001 — Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
Freeman et al. JExpMed 2000 — Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte
Diefenbach et al. NatImmunol 2000 — Ligands for the murine NKG2D receptor expression by tumor cells and activation of NK cells and macrophages
Johnson et al. ProcNatlAcadSciUSA 2000 — A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation
Nishimura et al. Immunity 1999 — Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying
Dong et al. NatMed 1999 — B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Groh et al. ProcNatlAcadSciUSA 1999 — Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
Rosenberg et al. NatMed 1998 — Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic
Yoshino et al. JpnJCancerRes 1997 — The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non-small
Groh et al. ProcNatlAcadSciUSA 1996 — Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
Leach et al. Science 1996 — Enhancement of antitumor immunity by CTLA-4 blockade
Houchins et al. JExpMed 1991 — DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human
Peters et al. Nature 1991 — Segregation of MHC class II molecules from MHC class I molecules in the golgi complex for transport to lysosomal
Berd et al. CancerRes 1988 — Effect of low dose cyclophosphamide on the immune system of cancer patients depletion of CD4+, 2h4+ suppressor-inducer
North et al. JExpMed 1982 — Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced

Basic-Neutrophil and myeloid cell

Bolli et al. CancerCell 2026 — CCL3 is produced by aged neutrophils across cancers and promotes tumor growth
Guo et al. CancerCell 2026 — Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche
Haist et al. CancerCell 2026 — Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting
Hayward et al. CancerCell 2026 — Tissue tension fosters macrophage-driven lipid peroxidation-induced DNA damage
Marteau et al. CancerCell 2026 — Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in
Shi et al. CancerCell 2026 — Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia
Zuo et al. CancerCell 2026 — IL-36gamma armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity
Lin et al. CancerDiscov 2026 — Arachidonic acid metabolism in PMN-MDSCs suppresses antitumor capacity of T cells in KRAS-mutant cholangiocarcinoma
Pillai et al. CancerDiscov 2026 — LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Qian et al. Cell 2026 — Respiratory viral infections prime accelerated lung cancer growth
Gao et al. CellMetab 2026 — Restricting lipid accumulation in tumor-infiltrating neutrophils mediates caloric restriction-induced anti-cancer
Lim et al. CellRep 2026 — Neutrophil-derived itaconate facilitates tiered pulmonary inflammation via kdm5b-associated epigenetic remodeling in
Meng et al. CellRep 2026 — Nociceptive neurons inhibit neutrophil extracellular trap formation via MLKL-licensed histone release
Ponessa et al. CellRep 2026 — Alveolar macrophages inhibit emphysematous pathology via expression of carbonic anhydrase 4
Hao et al. CellRepMed 2026 — Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative
Mestrallet et al. CellRepMed 2026 — Reprogramming t cell-myeloid crosstalk overcomes immune resistance in colorectal cancer
He et al. ChinMed 2026 — Shuangshen granules enhance anti-PD1 therapy effectiveness in lung adenocarcinoma by modulating myeloid-derived
Chen et al. ClinCancerRes 2026 — CCL3+ neutrophil signature predicts response to neoadjuvant toripalimab plus chemotherapy in patients with
Nemilostiva et al. ClinTranslOncol 2026 — CAR-engineered neutrophils derived from induced pluripotent stem cells a new frontier in cellular immunotherapy
McGarrity-Cottrell et al. FrontImmunol 2026 — Physiological, patho-physiological, and potential therapeutic roles for neutrophils in cancer & beyond
Wu et al. FrontImmunol 2026 — Tumor-associated neutrophils in pancreatic ductal adenocarcinoma mechanisms and therapeutic targeting
Huang et al. Immunity 2026 — Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis
Pires et al. Immunity 2026 — Innate lymphoid cells activated by the cytokine TL1A link colitis to emergency granulopoiesis and the recruitment of
Wang et al. JClinInvest 2026 — A CD138+ tumor-associated macrophagesiglec-f+ neutrophil feed-forward loop promotes immune evasion in pancreatic cancer
Bub et al. JExpMed 2026 — Sensing of metabolic signals via GPR183 promotes occupation of lung macrophage niches by monocytes
Smith et al. JImmunol 2026 — The paracrine factor myeloid derived growth factor regulates the inflammatory fate and motility of human induced
Lin et al. JImmunotherCancer 2026 — Integrin CD11bCD18 reprograms macrophage polarization by suppressing ERKSTAT3 signaling to enhance antitumor immunity
Redavid et al. JImmunotherCancer 2026 — Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy
Salladay-Perez et al. NatAging 2026 — P21+trem2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease
Chang et al. NatBiomedEng 2026 — CAR-neutrophils produced in vivo to treat glioma
Zhao et al. NatBiotechnol 2026 — A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors
Wang et al. NatCancer 2026 — CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8
Wan et al. NatCellBiol 2026 — Thy1+ cancer stem cells drive metastasis through a pseudohypoxic state shaped by neutrophil-derived mitochondria
Li et al. NatCommun 2026 — Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction
Boesch et al. NatGenet 2026 — Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic
Ghosh et al. NatImmunol 2026 — Chemokine-defined macrophage niches establish spatial organization of tumor immunity
Kerndl et al. NatImmunol 2026 — Monocyte infiltration induces CNS arginine catabolism to fuel neuroinflammation
Shahzad et al. NatRevCancer 2026 — Neutrophil extracellular traps in cancer
Cerezo-Wallis et al. Nature 2026 — Architecture of the neutrophil compartment
Fan et al. Nature 2026 — Submicrometre sampling of living cells by macrophages
Son et al. Nature 2026 — Neutrophils preserve energy storage in sympathetically activated adipocytes
Kalinowski et al. ProcNatlAcadSciUSA 2026 — Peripheral complement C4 protein in schizophrenia association with gene copy number and immune cell subtypes
Kusch et al. Science 2026 — Platelet-derived integrin-and tetraspanin-enriched tethers exacerbate severe inflammation
Henne et al. TrendsImmunol 2026 — TGF-beta A master regulator of tissue-resident macrophage identity and function
Zheng et al. TrendsImmunol 2026 — Bioelectric signaling as an emerging layer of macrophage communication
Alkan et al. bioRxiv 2026 — S100A9-dependent CXCR2hi neutrophils mediate systemic immune suppression and
Xu et al. bioRxiv 2026 — Neutrophils repurpose the nucleolus as a cytokine reservoir and secretory organelle
Wang et al. ACSApplMaterInterfaces 2025 — Neutrophil-mediated tumor discrimination biomimetic nanodevice for precise tumor eradication and metastasis cascade
Guan et al. AdvSci 2025 — Engineered bacterial outer membrane vesicles hitchhiking on neutrophils for antibody drug delivery to enhance
Chen et al. CancerCell 2025 — DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(l)1 therapy efficacy by degrading
He et al. CancerCell 2025 — Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps
Lee et al. CancerCell 2025 — Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells
Qian et al. CancerCell 2025 — A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven
Shi et al. CancerCell 2025 — CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone
Zhu et al. CancerCell 2025 — Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion
Sturgeon et al. Cancers 2025 — Neutrophil dynamics contribute to disease progression and poor survival in pancreatic cancer
Ballesteros et al. Cell 2025 — The neutrophil collective
Han et al. Cell 2025 — Tumors hijack macrophages for iron supply to promote bone metastasis and anemia
Hsu et al. Cell 2025 — Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution
Koenderman et al. CellMolImmunol 2025 — Neutrophils in cancer from biology to therapy
McDonald et al. CommunBiol 2025 — Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for
Zaranski et al. CommunBiol 2025 — NLRP3 inflammasome promotes PAD2 PAD4 release and protein citrullination in rheumatoid arthritis
Yang et al. FrontImmunol 2025 — Unveiling cd177 a key player in tumors, autoimmune diseases, and inflammatory disorders
Baron et al. FrontOncol 2025 — Neutrophil extracellular traps are associated with poor response to neoadjuvant therapy and poor survival in pediatric
Ng et al. Immunity 2025 — From complexity to consensus A roadmap for neutrophil classification
Li et al. MolImmunol 2025 — Neutrophil-derived exosomal S100A8 aggravates lung injury in sepsis by inducing pyroptosis
Yang et al. NatCommun 2025 — Extracellular matrix anchored neutrophils drive pulmonary fibrosis in mice
Sanchez-Garcia et al. NatImmunol 2025 — Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of
Adrover et al. Nature 2025 — Neutrophils drive vascular occlusion, tumour necrosis and metastasis
Burn et al. Nature 2025 — Myeloperoxidase transforms chromatin into neutrophil extracellular traps
Liu et al. Neuron 2025 — Lcn2 from neutrophil extracellular traps induces astrogliosis and post-stroke emotional disorders
Tavares et al. SciImmunol 2025 — SiglecF neutrophils
Zhou et al. SignalTransductTargetTher 2025 — Therapeutic potential of tumor-associated neutrophils dual role and phenotypic plasticity
Rys et al. TrendsCellBiol 2025 — Senescent neutrophils a hidden role in cancer progression
Zeng et al. ACSNano 2024 — Neutrophil nanodecoys inhibit tumor metastasis by blocking the interaction between tumor cells and neutrophils
Benguigui et al. CancerCell 2024 — Interferon-stimulated neutrophils as a predictor of immunotherapy response
He et al. CancerCell 2024 — Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment
Enfield et al. CancerDiscov 2024 — Spatial architecture of myeloid and T cells orchestrates immune evasion and clinical outcome in lung cancer
Mihlan et al. Cell 2024 — Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay
Wu et al. Cell 2024 — Neutrophil profiling illuminates anti-tumor antigen-presenting potency
Zhang et al. Cell 2024 — Cell surface RNAs control neutrophil recruitment
Ji et al. CellDeathDis 2024 — Chemerin attracts neutrophil reverse migration by interacting with C-C motif chemokine receptor-like 2
Xie et al. ExpHematolOncol 2024 — Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis
Malavez-Cajigas et al. Heliyon 2024 — HL-60 cells as a valuable model to study LPS-induced neutrophil extracellular traps release
Sun et al. Heliyon 2024 — Neutrophil extracellular trap genes predict immunotherapy response in gastric cancer
Madison et al. JLeukocBiol 2024 — In a sticky situation Pro-coagulant properties expand the importance of neutrophil EVs in driving tissue injury
Naveh et al. JTranslMed 2024 — Correction to neutrophils cultured ex vivo from CD34 + stem cells are immature and genetically tractable
Naveh et al. JTranslMed 2024 — Neutrophils cultured ex vivo from CD34+ stem cells are immature and genetically tractable
Zheng et al. NatCancer 2024 — Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity
Li et al. NatImmunol 2024 — Coordinated chemokine expression defines macrophage subsets across tissues
Lasser et al. NatRevClinOncol 2024 — Myeloid-derived suppressor cells in cancer and cancer therapy
Yu et al. Oncogene 2024 — Neutrophils in cancer dual roles through intercellular interactions
Meyerson et al. Poster 2024 — Serine Protease Inhibitors Enhance Neutrophil Survival
Chen et al. SSRN 2024 — Circulating cell-in-cell tumor cells with neutrophils signature are hematogenous metastasis-initiating cells
Ruscitti et al. SciImmunol 2024 — Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury
Ng et al. Science 2024 — Deterministic reprogramming of neutrophils within tumors
Horvath et al. TrendsCancer 2024 — Beyond binary bridging neutrophil diversity to new therapeutic approaches in NSCLC
Rabas et al. bioRxiv 2024 — Cancer-driven neutrophil priming couples systemic epithelial regenerative programs with pre-metastatic niche formation
Adrover et al. CancerCell 2023 — NETworking with cancer The bidirectional interplay between cancer and neutrophil extracellular traps
Haston et al. CancerCell 2023 — Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer
Mousset et al. CancerCell 2023 — Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-beta activation
Goldman et al. CancerDiscov 2023 — Early infiltration of innate immune cells to the liver depletes HNF4alpha and promotes extrahepatic carcinogenesis
Fu et al. CancerImmunolRes 2023 — Syntaphilin regulates neutrophil migration in cancer
Gungabeesoon et al. Cell 2023 — A neutrophil response linked to tumor control in immunotherapy
Hirschhorn et al. Cell 2023 — T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
Kloosterman et al. Cell 2023 — Macrophages at the interface of the co-evolving cancer ecosystem
Maas et al. Cell 2023 — The local microenvironment drives activation of neutrophils in human brain tumors
Kapellos et al. CellRep 2023 — Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
Zhang et al. ClinTranslMed 2023 — Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis
Wishart et al. CurrProtoc 2023 — Isolation of mouse neutrophils
Taifour et al. Immunity 2023 — The tumor-derived cytokine chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in
Sounbuli et al. IntJMolSci 2023 — A comparative study of different protocols for isolation of murine neutrophils from bone marrow and spleen
Luan et al. JInflammRes 2023 — Identification and analysis of neutrophil extracellular trap-related genes in osteoarthritis by bioinformatics and
Chang et al. NatCommun 2023 — CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Puttock et al. NatCommun 2023 — Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis
Taniguchi et al. NatCommun 2023 — In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
Barry et al. NatRevCancer 2023 — Therapeutic targeting of tumour myeloid cells
Wang et al. Nature 2023 — CD300ld on neutrophils is required for tumour-driven immune suppression
Kuang et al. STARProtoc 2023 — Protocol for density gradient neutrophil isolation and flow cytometry-based characterization from human peripheral blood
Poli et al. STARProtoc 2023 — Quantitative cytofluorimetric analysis of mouse neutrophil extracellular traps
Youn et al. SciAdv 2023 — Neutrophil-intrinsic TNF receptor signaling orchestrates host defense against staphylococcus aureus
Gong et al. SciImmunol 2023 — Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis
Strickland et al. iScience 2023 — Alternatively activated lung alveolar and interstitial macrophages promote fungal growth
He et al. AnnuRevCancerBiol 2022 — Caught in a web Emerging roles of neutrophil extracellular traps in cancer
Salcher et al. CancerCell 2022 — High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell
Ozel et al. Cancers 2022 — The good, the bad, and the ugly neutrophils, angiogenesis, and cancer
Neuenfeldt et al. CellRep 2022 — Inflammation induces pro-NETotic neutrophils via TNFR2 signaling
Gutierrez et al. Cells 2022 — Human neutrophils generate extracellular vesicles that modulate their functional responses
Zhou et al. Cells 2022 — Neutrophil extracellular vesicles A delicate balance between pro-inflammatory responses and anti-inflammatory therapies
Pfister et al. Diagnostics 2022 — Neutrophil extracellular traps and neutrophil-derived extracellular vesicles common players in neutrophil effector
Iqbal et al. FASEBJ 2022 — Galectin-9 mediates neutrophil capture and adhesion in a CD44 and beta2 integrin-dependent manner
Abbas et al. FrontImmunol 2022 — Conventional therapies deplete brain-infiltrating adaptive immune cells in a mouse model of group 3 medulloblastoma
Chen et al. FrontImmunol 2022 — Roles of the exosomes derived from myeloid-derived suppressor cells in tumor immunity and cancer progression
Wang et al. FrontImmunol 2022 — Neutrophil extracellular traps promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activa…
Aegerter et al. Immunity 2022 — Biology of lung macrophages in health and disease
Marki et al. ImmunolRev 2022 — The expanding family of neutrophil-derived extracellular vesicles
Pan et al. Inflammation 2022 — The effect and mechanism of lipoxin A4 on neutrophil function in LPS-induced lung injury
Song et al. JCIInsight 2022 — PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils
Wigerblad et al. JImmunol 2022 — Single-cell analysis reveals the range of transcriptional states of circulating human neutrophils
Pisaneschi et al. NatBiotechnol 2022 — Imaging of innate immunity activation in vivo with a redox-tuned PET reporter
Su et al. NatCardiovascRes 2022 — Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis
Chen et al. NatCommun 2022 — Cancer co-opts differentiation of b-cell precursors into macrophage-like cells
Hedrick et al. NatRevImmunol 2022 — Neutrophils in cancer heterogeneous and multifaceted
Kim et al. Nature 2022 — Ferroptosis of tumour neutrophils causes immune suppression in cancer
Xue et al. Nature 2022 — Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
Raskov et al. Oncogenesis 2022 — Neutrophils and polymorphonuclear myeloid-derived suppressor cells an emerging battleground in cancer therapy
Tang et al. SciAdv 2022 — Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain
Scieszka et al. SciData 2022 — NETome A model to decode the human genome and proteome of neutrophil extracellular traps
Muendlein et al. SciImmunol 2022 — Neutrophils and macrophages drive TNF-induced lethality via TRIF-CD14-mediated responses
Nakamura et al. SciRep 2022 — Mycobacterium avium-intracellulare complex promote release of pro-inflammatory enzymes matrix metalloproteinases by i…
三好 et al. 血栓止血誌 2022 — NETsの測定方法と臨床的意義
Xiao et al. CancerCell 2021 — Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular
Cheng et al. Cell 2021 — A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Teijeira et al. ClinCancerRes 2021 — IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy
Tokuhiro et al. FrontCellDevBiol 2021 — Oxidized phospholipids and neutrophil elastase coordinately play critical roles in NET formation
Hardisty et al. FrontImmunol 2021 — High purity isolation of low density neutrophils casts doubt on their exceptionality in health and disease
Burn et al. Immunity 2021 — The neutrophil
Zhu et al. IntJMolMed 2021 — Neutrophil extracellular traps promote gastric cancer metastasis by inducing epithelial-mesenchymal transition
Kato et al. IntJMolSci 2021 — Effects of thrombomodulin in reducing lethality and suppressing neutrophil extracellular trap formation in the lungs
Nogales-Pons et al. JExpMed 2021 — Myeloid diversity in tumors shaped by genes, location, and time
Veglia et al. JExpMed 2021 — Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and
Yang et al. JImmunotherCancer 2021 — Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis
Brandau et al. MethodMolBiol 2021 — Myeloid-derived suppressor cells methods and protocols
Chen et al. MolTher 2021 — Microglial lnc-U90926 facilitates neutrophil infiltration in ischemic stroke via MDH2CXCL2 axis
Grieshaber-Bouyer et al. NatCommun 2021 — The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments
Valero et al. NatCommun 2021 — Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint
Li et al. NatImmunol 2021 — Targeting resident macrophages in cancer
Veglia et al. NatRevImmunol 2021 — Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Carminita et al. ProcNatlAcadSciUSA 2021 — DNase-dependent NET-indepenedent pathway of thrombus formation in vivo
Cui et al. STARProtoc 2021 — Isolation of polymorphonuclear neutrophils and monocytes from a single sample of human peripheral blood
McGill et al. STARProtoc 2021 — Protocol for analysis of mouse neutrophil NETosis by flow cytometry
Fan et al. SciTranslMed 2021 — Targeting multiple cell death pathways extends the shelf life and preserves the function of human and mouse neutrophils
Aloe et al. TranslLungCancerRes 2021 — Emerging and multifaceted role of neutrophils in lung cancer
大坂 et al. 血栓止血誌 2021 — NETsと癌
Okeke et al. Biomaterials 2020 — Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock
Xu et al. CancerImmunolRes 2020 — Chemotherapeutic tumor microparticles elicit a neutrophil response targeting malignant pleural effusions
Wu et al. Cancers 2020 — Breast cancer cell-neutrophil interactions enhance neutrophil survival and pro-tumorigenic activities
Ballesteros et al. Cell 2020 — Co-option of neutrophil fates by tissue environments
Metzemaekers et al. CellMolImmunol 2020 — Neutrophil chemoattractant receptors in health and disease Double-edged swords
Pfirschke et al. CellRep 2020 — Tumor-promoting ly-6g+ SiglecFhigh cells are mature and long-lived neutrophils
Tsourouktsoglou et al. CellRep 2020 — Histones, DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and
Kolonics et al. Cells 2020 — The functional heterogeneity of neutrophil-derived extracellular vesicles reflects the status of the parent cell
Masucci et al. FrontImmunol 2020 — The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis
Ohms et al. FrontImmunol 2020 — An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro
Teijeira et al. Immunity 2020 — CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere
Lecoultre et al. JImmunotherCancer 2020 — Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control a review
Quinn et al. MethodMolBiol 2020 — Neutrophil
Li et al. NatImmunol 2020 — Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis
Xie et al. NatImmunol 2020 — Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection
Schalper et al. NatMed 2020 — Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of
Jaillon et al. NatRevCancer 2020 — Neutrophil diversity and plasticity in tumour progression and therapy
Nemeth et al. NatRevDrugDiscov 2020 — Neutrophils as emerging therapeutic targets
Flemming et al. NatRevImmunol 2020 — Tumours use NETs as physical shields
Yang et al. Nature 2020 — DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
Liu et al. STARProtoc 2020 — Analysis of myeloid cells in mouse tissues with flow cytometry
Sollberger et al. eLife 2020 — Linker histone H1.2 and H1.4 affect the neutrophil lineage determination
Thalin et al. ArteriosclerThrombVascBiol 2019 — Neutrophil extracellular traps villains and targets in arterial, venous, and cancer-associated thrombosis
Giese et al. Blood 2019 — Neutrophil plasticity in the tumor microenvironment
Yazdani et al. CancerRes 2019 — Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth
Hoogendijk et al. CellRep 2019 — Dynamic transcriptome-proteome correlation networks reveal human myeloid differentiation and neutrophil-specific
LoRusso et al. ClinCancerRes 2019 — Antibody-FcFcR interaction on macrophages as a mechanism for hyperprogressive disease in non-small cell lung cancer
Adrover et al. Immunity 2019 — A neutrophil timer coordinates immune defense and vascular protection
Zilionis et al. Immunity 2019 — Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals
Rayes et al. JCIInsight 2019 — Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects
Lee et al. JExpMed 2019 — Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
Tong et al. JImmunol 2019 — Lipopolysaccharide-stimulated human fetal membranes induce neutrophil activation and release of vital neutrophil
Abu et al. JVisExp 2019 — Immunofluorescence labelling of human and murine neutrophil extracellular traps in paraffin-embedded tissue
Rada et al. MethodMolBiol 2019 — Neutrophil extracellular traps
Aran et al. NatImmunol 2019 — Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Radermecker et al. NatImmunol 2019 — Locally instructed CXCR4hi neutrophils trigger environment-driven allergic asthma through the release of neutrophil
Ng et al. NatRevImmunol 2019 — Heterogeneity of neutrophils
Szczerba et al. Nature 2019 — Neutrophils escort circulating tumour cells to enable cell cycle progression
Veglia et al. Nature 2019 — Fatty acid transport protein 2 reprograms neutrophils in cancer
Chakarov et al. Science 2019 — Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches
Rocks et al. Thorax 2019 — Ozone-primed neutrophils promote early steps of tumour cell metastasis to lungs by enhancing their NET production
Cassatella et al. TrendsImmunol 2019 — Biological roles of neutrophil-derived granule proteins and cytokines
Evrard et al. Immunity 2018 — Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and
Condon et al. JCellBiol 2018 — Macropinosome formation by tent pole ruffling in macrophages
Sekine et al. LungCancer 2018 — Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in
Zhang et al. MolCancer 2018 — Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration
Inoue et al. NatCommun 2018 — Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis
Patin et al. NatImmunol 2018 — Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Papayannopoulos et al. NatRevImmunol 2018 — Neutrophil extracellular traps in immunity and disease
Zou et al. Oncotarget 2018 — Neutrophil extracellular traps promote lipopolysaccharide-induced airway inflammation and mucus hypersecretion in mice
Krishnamoorthy et al. SciImmunol 2018 — Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma
Sollberger et al. SciImmunol 2018 — Gasdermin D plays a vital role in the generation of neutrophil extracellular traps
Albrengues et al. Science 2018 — Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
Kang et al. ACSNano 2017 — Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis
Teng et al. AmJHematol 2017 — Heterogeneity of neutrophil spontaneous death
Gibbings et al. AmJRespirCellMolBiol 2017 — Three unique interstitial macrophages in the murine lung at steady state
Noubouossie et al. Blood 2017 — In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps
Sabatel et al. Immunity 2017 — Exposure to bacterial CpG DNA protects from airway allergic inflammation by expanding regulatory lung interstitial
Kim et al. JInvestDermatol 2017 — Phenformin inhibits myeloid-derived suppressor cells and enhances the anti-tumor activity of PD-1 blockade in melanoma
Piccolo et al. NatImmunol 2017 — Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk
Xue et al. NatNanotechnol 2017 — Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
Gordon et al. Nature 2017 — PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Leal et al. SciRep 2017 — Tumor-derived exosomes induce the formation of neutrophil extracellular traps implications for the establishment of
Engblom et al. Science 2017 — Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils
Russell et al. AnnAmThoracSoc 2016 — Neutrophil fates in bronchiectasis and alpha-1 antitrypsin deficiency
Singhal et al. CancerCell 2016 — Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human
Koyama et al. CancerRes 2016 — STK11LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T-cell
Tohme et al. CancerRes 2016 — Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress
deBuhr et al. JImmunolRes 2016 — How neutrophil extracellular traps become visible
Bronte et al. NatCommun 2016 — Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Coffelt et al. NatRevCancer 2016 — Neutrophils in cancer neutral no more
DeHenau et al. Nature 2016 — Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells
Demers et al. OncoImmunology 2016 — Priming of neutrophils toward NETosis promotes tumor growth
Condamine et al. SciImmunol 2016 — Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor
Liu et al. SciRep 2016 — Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury
Park et al. SciTranslMed 2016 — Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Gavillet et al. AmJHematol 2015 — Flow cytometric assay for direct quantification of neutrophil extracellular traps in
Sagiv et al. CellRep 2015 — Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer
Swamydas et al. CurrProtocImmunol 2015 — Isolation of mouse neutrophils
Kopf et al. NatImmunol 2015 — The development and function of lung-resident macrophages and dendritic cells
Coffelt et al. Nature 2015 — IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis
Wculek et al. Nature 2015 — Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Casbon et al. ProcNatlAcadSciUSA 2015 — Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive
Warnatsch et al. Science 2015 — Inflammation. neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Rossaint et al. Blood 2014 — Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile
Hamaguchi et al. EurRespirJ 2014 — Neutrophil extracellular traps in bronchial aspirates a quantitative analysis
Eruslanov et al. JClinInvest 2014 — Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Cools-Lartigue et al. JClinInvest 2013 — Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Swamydas et al. JVisExp 2013 — Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer
Gabrilovich et al. NatRevImmunol 2012 — Coordinated regulation of myeloid cells by tumours
Cortez-Retamozo et al. ProcNatlAcadSciUSA 2012 — Origins of tumor-associated macrophages and neutrophils
Ivan et al. AnnuIntConfIEEEEngMedBiolSoc 2011 — Estimation of the population of neutrophils induced to differentiate from the MPRO mouse promyelocytic cell line
Granot et al. CancerCell 2011 — Tumor entrained neutrophils inhibit seeding in the premetastatic lung
Qian et al. Nature 2011 — CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Brinkmann et al. JVisExp 2010 — Neutrophil extracellular traps how to generate and visualize them
Ray et al. JVisExp 2010 — Isolation of mouse peritoneal cavity cells
Heinz et al. MolCell 2010 — Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage
Fuchs et al. ProcNatlAcadSciUSA 2010 — Extracellular DNA traps promote thrombosis
Fridlender et al. CancerCell 2009 — Polarization of tumor-associated neutrophil phenotype by TGF-beta N1 versus N2 TAN
Kessenbrock et al. NatMed 2009 — Netting neutrophils in autoimmune small-vessel vasculitis
Gabrilovich et al. NatRevImmunol 2009 — Myeloid-derived suppressor cells as regulators of the immune system
Kim et al. Nature 2009 — Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Fuchs et al. JCellBiol 2007 — Novel cell death program leads to neutrophil extracellular traps
Gaines et al. CurrProtocImmunol 2005 — Differentiation and characterization of myeloid cells
Brinkmann et al. Science 2004 — Neutrophil extracellular traps kill bacteria
Blood 2002 — Genomic and proteomic analysis of the myeloid differentiation program Global analysis of gene expression during induc…
Weiler et al. Blood 1999 — D3 a gene induced during myeloid cell differentiation of linlo c-kit+ sca-1(+) progenitor cells
Tsai et al. ProcNatlAcadSciUSA 1993 — A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage

Research Wiki

エクスプローラー

cancer-neutrophils